« Back

Bill T. Ameredes, PhD
Associate Professor, Division of Pulmonary Critical Care & Sleep Medicine



Bill T. Ameredes, PhD

Bill T. Ameredes, PhD
Associate Professor of Medicine
Associate Professor of Preventive Medicine and Community Health
Associate Professor of Biochemistry and Molecular Biology
William C. Levin Chair, Environmental Toxicology
Associate Director, Coordination Key Resource, NIH CTSA
Director, Environmental Inhalation Exposure Facility
Director, NIEHS Environmental Toxicology Training Program
Distinguished Teaching Professor, Academy of Master Teachers

University of Texas Medical Branch
Division of Pulmonary, and Critical Care Medicine
Medical Research Building 8.104
301 University Blvd.
Galveston, TX 77555-1083
Phone: 409.772.8104
Fax: 409.772.5841
btamered@utmb.edu

Education

Degree/Training Completed Year Name & Location
Ph.D. 1989 Ohio State University, Columbus, Ohio
Post-Doctoral Training 1990 University of Florida, Gainesville, FL
Post-Doctoral Fellowship 1992 University of Florida, Gainesville, FL

Research Interests

  • Airway smooth muscle biology and beta-receptor regulation
  • Immune/inflammatory cytokine responses of the airway
  • Beta-agonist regulation of MAPK mechanisms
  • Role of carbon monoxide in airway inflammation
  • Role of nitric oxide in airway inflammation

Selected Publications

  1. Ameredes, BT. Beta-2-receptor regulation of immunomodulatory proteins in airway smooth muscle. Frontiers in Bioscience (Schol Ed). 3:643-54, 2011.
  2. Ameredes, BT. Translating airway biomarker information into practice: from theoretical science to applied medicine. Pulm Pharmacol Ther. Sep 30. [Epub ahead of print] 2010.
  3. Ameredes BT, Sethi JM, Liu H, Choi AMK, Calhoun WJ: Enhanced nitric oxide production associated with airway hyporesponsiveness in the absence of IL-10. Am. J. Physiol. Lung Cell Mol. Physiol. 288:L868-L873, 2005.
  4. Ameredes BT, Calhoun WJ: Modulation of GM-CSF by enantiomeric beta-agonists in human airway smooth muscle. J. Allergy Clin. Immunol. 116(1):65-72, 2005.
  5. Ameredes BT: Cardiac activity during airway resistance alterations with intravenous and inhaled methacholine. Respir. Physiol. Neurobiol. 139(3):281-292, 2004.

»Pub Med Search
»Curriculum Vitae

The department of internal medicine is developing evidence based clinical protocols which will be available in EPIC (as order sets) for use when admitting patients with these diagnoses. Their AIM is to standardize care and decrease length of stay and readmission rates.

Currently available protocols are:
  • CAP - Community Acquired Pneumonia Orderset
  • Congestive Heart Failure (CHF)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Diabetic Ketoacidosis Adult, ICU
  • General Medicine Admission
  • Immunodeficiency Flow Panel
  • MICU/CCU Admission Order Set
  • Oral Analgesic Medicaitons
  • Parenteral Opioids
  • Sepsis, Adult ICU
  • 111 - Stroke Alert
  • 112 - Stroke Activation
  • 300086 - Stroke Floor Admission
  • 3000000001 -  Stroke Critical care without tPA
  • 300088 Stroke - Transfer from Critical care to floor
  • 3004002 - Stroke Discharge

All protocols can be found in the EPIC order set section.

» For more information

Meaning Use logo

The department of Internal Medicine has a large role in the Meaningful Use Initiative. Our participation is key for the success of the initiative. Please visit the meaningful use website for important communication and updates from the Meaningful Use Initiative.

Site Managed by UTMB Information Design Services.